CAREDX, INC. Cash and Cash Equivalents, Period Increase (Decrease)
CAREDX, INC. (CDNA) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$363.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-22.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-03-22
- CAREDX, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $10.92M.
- CAREDX, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$3.13M, a 161.08% decline year-over-year.
- CAREDX, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$3.08M.
- CAREDX, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$5.07M.
- CAREDX, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$363.00K.
- CAREDX, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$12.63M.
- CAREDX, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$6.54M, a 120.90% decline from fiscal 2014.
- CAREDX, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $31.30M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $10.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $7.79M derived: sum of 2 quarters · filed 2018-03-22 | $4.71M derived: sum of 3 quarters · filed 2018-03-22 | -$363.00K 10-K · filed 2018-03-22 |
| 2017-09-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$6.21M derived: sum of 2 quarters · filed 2017-11-09 | -$11.28M 10-Q · filed 2017-11-09 | -$16.29M derived: sum of 4 quarters · filed 2018-03-22 |
| 2017-06-30 | -$3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$8.15M 10-Q · filed 2017-08-11 | -$13.16M derived: sum of 3 quarters · filed 2018-03-22 | -$8.04M derived: sum of 4 quarters · filed 2018-03-22 |
| 2017-03-31 | -$5.07M 10-Q · filed 2017-06-09 | -$10.08M derived: sum of 2 quarters · filed 2018-03-22 | -$4.96M derived: sum of 3 quarters · filed 2018-03-22 | -$11.56M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-12-31 | -$5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $114.00K derived: sum of 2 quarters · filed 2018-03-22 | -$6.49M derived: sum of 3 quarters · filed 2018-03-22 | -$12.63M 10-K · filed 2018-03-22 |
| 2016-09-30 | $5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.49M derived: sum of 2 quarters · filed 2017-11-09 | -$7.62M 10-Q · filed 2017-11-09 | -$11.69M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-06-30 | -$6.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$12.74M 10-Q · filed 2017-08-11 | -$16.81M derived: sum of 3 quarters · filed 2018-03-22 | -$19.75M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-03-31 | -$6.14M 10-Q · filed 2017-06-09 | -$10.20M derived: sum of 2 quarters · filed 2018-03-22 | -$13.14M derived: sum of 3 quarters · filed 2018-03-22 | -$15.23M derived: sum of 4 quarters · filed 2018-03-22 |
| 2015-12-31 | -$4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | -$7.01M derived: sum of 2 quarters · filed 2018-03-22 | -$9.10M derived: sum of 3 quarters · filed 2018-03-22 | -$6.54M 10-K · filed 2018-03-22 |
| 2015-09-30 | -$2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$5.03M derived: sum of 2 quarters · filed 2016-11-14 | -$2.48M 10-Q · filed 2016-11-14 | -$5.09M derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-22 | $463.00K 10-Q · filed 2016-08-22 | -$2.15M derived: sum of 3 quarters · filed 2017-04-21 | $29.02M derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-03-31 | $2.55M 10-Q · filed 2016-05-16 | -$63.00K derived: sum of 2 quarters · filed 2017-04-21 | $31.11M derived: sum of 3 quarters · filed 2017-04-21 | $34.15M derived: sum of 4 quarters · filed 2017-04-21 |
| 2014-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21 | $28.56M derived: sum of 2 quarters · filed 2017-04-21 | $31.59M derived: sum of 3 quarters · filed 2017-04-21 | $31.30M 10-K · filed 2017-04-21 |
| 2014-09-30 | $31.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $34.21M derived: sum of 2 quarters · filed 2015-11-13 | $33.92M 10-Q · filed 2015-11-13 | $32.96M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-28 | $2.74M 10-Q · filed 2015-08-12 | $1.78M derived: sum of 3 quarters · filed 2016-03-29 | $3.39M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | -$291.00K 10-Q · filed 2015-05-14 | -$1.25M derived: sum of 2 quarters · filed 2016-03-29 | $352.00K derived: sum of 3 quarters · filed 2016-03-29 | |
| 2013-12-31 | -$963.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $643.00K derived: sum of 2 quarters · filed 2016-03-29 | -$702.00K 10-K · filed 2016-03-29 | |
| 2013-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $261.00K 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | -$1.34M 10-Q · filed 2014-08-28 | |||
| 2012-12-31 | $3.47M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |